Methexis Genomics SA
Methexis Genomics reported total assets of 51,405 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Jun 2026).
The score of Methexis Genomics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +29 % Total assets -2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Methexis Genomics's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jun 2026
- Year ended 31 Dec 2024filed on 02 Jun 2025
- Year ended 31 Dec 2023filed on 17 Jun 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 21 Aug 2022
Methexis Genomics's financial analysis
- Solvency95.6%sector median: 57.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Methexis Genomics
Methexis Genomics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0464.995.135
- VAT number
- BE0464995135
- Peppol
- Registered · 0208:0464995135 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 23 Dec 1998
- Registered office
- 9000 Ghent
- Latest accounts
- 2025 · filed on 28 Jun 2026
- Activity
- Engineering activities and technical consultancy, except activities of land surveyors (NACE 71121)
Methexis Genomics (SA) has been based in Ghent since 1998, active in: engineering activities and technical consultancy, except activities of land surveyors. For 2025, it reports a net loss of 8,170 € and equity of 49,156 €; its revenue is not published. Its solvency stands at 95.6%, above the median of its sector (57.7%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Methexis Genomics
Companies in the same business, of comparable size and area, outside its group.
- Ganbomar Engineering activities and related technical consultancy Lochristi · balance sheet 51,395 €
- /' vigər/ Engineering activities and related technical consultancy Aalter · balance sheet 51,220 €
- Coursier Frans Engineering activities and related technical consultancy Londerzeel · balance sheet 51,933 €
- Buro Benton Engineering activities and related technical consultancy Merelbeke-Melle · balance sheet 49,363 €
- SDC Consultancy Engineering activities and related technical consultancy Ghent · balance sheet 49,296 €
- Trae Consulting Engineering activities and related technical consultancy Ghent · balance sheet 54,997 €
- B-Tech Partner Engineering activities and related technical consultancy Waregem · balance sheet 55,704 €
- Paralleles Engineering activities and related technical consultancy Flémalle · balance sheet 52,388 €
Frequently asked questions about Methexis Genomics
What is the revenue of Methexis Genomics?
Methexis Genomics files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Methexis Genomics?
In Belgium, the VAT number is the company number prefixed with BE: BE0464995135 for Methexis Genomics, if the company is VAT-registered. Its company number (CBE) is 0464.995.135.
Where is the registered office of Methexis Genomics?
According to the CBE register, the registered office of Methexis Genomics is in 9000 Ghent.
What is the equity of Methexis Genomics?
At the close of the 2025 financial year, the equity of Methexis Genomics amounts to 49,156 €, a solvency of 95.6% of total assets.
Who manages Methexis Genomics?
The register lists 1 active mandates at Methexis Genomics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Methexis Genomics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →